Diabetic peripheral neuropathy is one of the most common complications of diabetes, often causing loss of sensation, foot ulcers, and in severe cases, amputation¹.

Treating these complications can be costly², but many can be prevented³, making early detection and intervention crucial for improving patient outcomes and reducing healthcare expenses.

Neuropen® is the only peripheral neuropathy screening device that combines both pressure and sharpness tests, offering healthcare professionals a simple, compact solution for assessing both large and small nerve fibers in the foot.

Peripheral neuropathy can’t be ruled out without regular foot screening alongside symptoms and clinical evaluations.

Neuropen® supports this screening process by setting a new standard – it’s the first dual-purpose, pocket-sized device built for safe and reliable testing.

How Neuropen® works

The Neuropen® device is reusable and can perform:

• A 10g pressure test with Neuropen® Monofilaments to check for decreased sensation in the area tested.
• A 40g sharpness test with Neurotips single-use neuro exam pins to assess reduced sensitivity to sharpness or pain in small nerve fibers.